Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein receptor type II is an essential component of TGF-beta family signaling pathways regulating diverse developmental processes across tissues. Mutations disrupting its function are causally linked to heritable forms of pulmonary arterial hypertension due to abnormal vascular remodeling driven by imbalanced cellular proliferation/apoptosis dynamics.
Selective inhibitors targeting overactive BMPR kinases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone morphogenetic protein receptor type II (None).